Long Non-coding RNA KCNQ1OT1 Up-regulates CTNND1 by Sponging MiR-329-3p to Induce the Proliferation, Migration, Invasion, and Inhibit Apoptosis of Colorectal Cancer Cells

Overview

Journal Cancer Cell Int

Publisher Biomed Central

Date 2020 Aug 8

PMID 32760218

Citations 6

Authors

Xing Liu

Yexiang Zhang

Yan Wang

Chao Bian

Fengji Wang

Affiliations

Soon will be listed here.

Abstract

Background: Long non-coding RNAs (lncRNAs) have been certified to be involved in the occurrence and growth of diverse cancers, including CRC. The purpose of the research was to explore the effects of lncRNA KCNQ1 overlapping transcript 1 (KCNQ1OT1) on proliferation, migration, invasion, and apoptosis in CRC cells and its mechanism.

Methods: The levels of KCNQ1OT1 and miR-329-3p were examined by quantitative real-time polymerase chain reaction (qRT-PCR) in CRC tissues and cells. The mRNA and protein levels of catenin delta-1 (CTNND1) were measured by qRT-PCR and western blot analysis, respectively. The targets of KCNQ1OT1 and miR-329-3p were predicted by online software and confirmed by luciferase reporter assay. The cell proliferation, migration, invasion, and apoptosis were examined using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT), transwell, and apoptosis assay. The expression levels of CyclinD1, Bcl-2, MMP9, Cleaved-casp-3, and E-cadherin in SW480 and LS1034 cells were gauged by western blot analysis. Xenograft tumor model was structured to prove the biological role of KCNQ1OT1 of CRC in vivo.

Results: The levels of KCNQ1OT1 and CTNND1 were significantly increased in CRC tissues and cells. Knockdown of KCNQ1OT1 suppressed proliferation, migration, invasion, and induced apoptosis in CRC cells. Conversely, CTNND1 overexpression reversed the impact of KCNQ1OT1 knockdown on CRC cells. Moreover, CTNND1 was verified as a direct target of miR-329-3p, and miR-329-3p could specially bind to KCNQ1OT1. Also, the down-regulation of KCNQ1OT1 triggered the CRC progress by up-regulating CTNND1 expression in CRC cells. Besides, KCNQ1OT1 knockdown inhibited CRC tumor growth through the miR-329-3p/CTNND1 axis in vivo.

Conclusion: Our results indicated that KCNQ1OT1 could positively regulate CTNND1 expression by sponging miR-329-3p, thereby boosting the progression of CRC. Our findings provided the underlying therapy targets for CRC.

Citing Articles

Global MicroRNA Profiling of HSV-1 Infected Cornea Identifies miR-329 as a Novel Regulator of Virus Infection.

Sharma P, Naqvi R, Borase H, Kapoor D, Valverde A, Capistrano K Invest Ophthalmol Vis Sci. 2025; 66(2):61.

PMID: 39992671 PMC: 11878248. DOI: 10.1167/iovs.66.2.61.

MicroRNA-329-3p inhibits the Wnt/β-catenin pathway and proliferation of osteosarcoma cells by targeting transcription factor 7-like 1.

Sun H, Kawano M, Iwasaki T, Itonaga I, Kubota Y, Tsumura H Oncol Res. 2024; 32(3):463-476.

PMID: 38370338 PMC: 10874473. DOI: 10.32604/or.2023.044085.

Long noncoding RNA PSMA3-AS1 functions as a competing endogenous RNA to promote gastric cancer progression by regulating the miR-329-3p/ALDOA axis.

Kan L, Yang M, Zhang H Biol Direct. 2023; 18(1):36.

PMID: 37403106 PMC: 10318671. DOI: 10.1186/s13062-023-00392-8.

The involvement and therapeutic potential of lncRNA Kcnq1ot1/miR-34a-5p/Sirt1 pathway in arsenic trioxide-induced cardiotoxicity.

Shen X, Zhi F, Shi C, Xu J, Chao Y, Xu J J Transl Med. 2023; 21(1):52.

PMID: 36707890 PMC: 9883885. DOI: 10.1186/s12967-023-03895-0.

KCNQ1OT1: An Oncogenic Long Noncoding RNA.

Cagle P, Qi Q, Niture S, Kumar D Biomolecules. 2021; 11(11).

PMID: 34827600 PMC: 8615887. DOI: 10.3390/biom11111602.

References

Prensner J, Chinnaiyan A . The emergence of lncRNAs in cancer biology. Cancer Discov. 2011; 1(5):391-407. PMC: 3215093. DOI: 10.1158/2159-8290.CD-11-0209. View

Shou X, Li Y, Hu W, Ye T, Wang G, Xu F . Six-gene Assay as a new biomarker in the blood of patients with colorectal cancer: establishment and clinical validation. Mol Oncol. 2018; 13(4):781-791. PMC: 6441906. DOI: 10.1002/1878-0261.12427. View

Malvi P, Chaube B, Singh S, Mohammad N, Pandey V, Vijayakumar M . Weight control interventions improve therapeutic efficacy of dacarbazine in melanoma by reversing obesity-induced drug resistance. Cancer Metab. 2016; 4:21. PMC: 5142287. DOI: 10.1186/s40170-016-0162-8. View

Singh S, Ajay A, Mohammad N, Malvi P, Chaube B, Meena A . Proteasomal inhibition sensitizes cervical cancer cells to mitomycin C-induced bystander effect: the role of tumor microenvironment. Cell Death Dis. 2015; 6:e1934. PMC: 4632313. DOI: 10.1038/cddis.2015.292. View

Cong N, Du P, Zhang A, Shen F, Su J, Pu P . Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Oncol Rep. 2013; 29(4):1579-87. DOI: 10.3892/or.2013.2267. View

Liu G, Zhang X, Lin H, Wang H, Li Q, Ni J . Effects of E-cadherin on mouse embryo implantation and expression of matrix metalloproteinase-2 and -9. Biochem Biophys Res Commun. 2006; 343(3):832-8. DOI: 10.1016/j.bbrc.2006.02.189. View

Wu F, Xing T, Gao X, Liu F . miR‑501‑3p promotes colorectal cancer progression via activation of Wnt/β‑catenin signaling. Int J Oncol. 2019; 55(3):671-683. PMC: 6685591. DOI: 10.3892/ijo.2019.4852. View

Zhu Y, Tchkonia T, Fuhrmann-Stroissnigg H, Dai H, Ling Y, Stout M . Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors. Aging Cell. 2015; 15(3):428-35. PMC: 4854923. DOI: 10.1111/acel.12445. View

Hong J, Park J, Cho K, Gu D, Ji H, Artandi S . Shared molecular mechanisms regulate multiple catenin proteins: canonical Wnt signals and components modulate p120-catenin isoform-1 and additional p120 subfamily members. J Cell Sci. 2010; 123(Pt 24):4351-65. PMC: 2995616. DOI: 10.1242/jcs.067199. View

10.

Chang Y, Yin F, Fan G, Zhao M . Down-regulation of miR-329-3p is associated with worse prognosis in patients with cervical cancer. Eur Rev Med Pharmacol Sci. 2017; 21(18):4045-4049. View

11.

Zhang K, Yan J, Yi B, Rui Y, Hu H . High KCNQ1OT1 expression might independently predict shorter survival of colon adenocarcinoma. Future Oncol. 2019; 15(10):1085-1095. DOI: 10.2217/fon-2018-0499. View

12.

Xian D, Zhao Y . LncRNA KCNQ1OT1 enhanced the methotrexate resistance of colorectal cancer cells by regulating miR-760/PPP1R1B via the cAMP signalling pathway. J Cell Mol Med. 2019; 23(6):3808-3823. PMC: 6533496. DOI: 10.1111/jcmm.14071. View

13.

Rogers C, Fernandes-Alnemri T, Mayes L, Alnemri D, Cingolani G, Alnemri E . Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death. Nat Commun. 2017; 8:14128. PMC: 5216131. DOI: 10.1038/ncomms14128. View

14.

Wang P, Ning S, Zhang Y, Li R, Ye J, Zhao Z . Identification of lncRNA-associated competing triplets reveals global patterns and prognostic markers for cancer. Nucleic Acids Res. 2015; 43(7):3478-89. PMC: 4402541. DOI: 10.1093/nar/gkv233. View

15.

Singh S, Chouhan S, Mohammad N, Bhat M . Resistin causes G1 arrest in colon cancer cells through upregulation of SOCS3. FEBS Lett. 2017; 591(10):1371-1382. DOI: 10.1002/1873-3468.12655. View

16.

Muhammad N, Steele R, Isbell T, Philips N, Ray R . Bitter melon extract inhibits breast cancer growth in preclinical model by inducing autophagic cell death. Oncotarget. 2017; 8(39):66226-66236. PMC: 5630406. DOI: 10.18632/oncotarget.19887. View

17.

Liang W, Fu W, Wong C, Wang Y, Wang W, Hu G . The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget. 2015; 6(26):22513-25. PMC: 4673179. DOI: 10.18632/oncotarget.4154. View

18.

Tang B, Tang F, Wang Z, Qi G, Liang X, Li B . Overexpression of CTNND1 in hepatocellular carcinoma promotes carcinous characters through activation of Wnt/β-catenin signaling. J Exp Clin Cancer Res. 2016; 35(1):82. PMC: 4872337. DOI: 10.1186/s13046-016-0344-9. View

19.

Li Y, Li C, Li D, Yang L, Jin J, Zhang B . lncRNA KCNQ1OT1 enhances the chemoresistance of oxaliplatin in colon cancer by targeting the miR-34a/ATG4B pathway. Onco Targets Ther. 2019; 12:2649-2660. PMC: 6462170. DOI: 10.2147/OTT.S188054. View

20.

Chen X, Zhang Z, Ma Y, Su H, Xie P, Ran J . LINC02381 Promoted Cell Viability and Migration via Targeting miR-133b in Cervical Cancer Cells. Cancer Manag Res. 2020; 12:3971-3979. PMC: 7261661. DOI: 10.2147/CMAR.S237285. View